Skip to main content
Christopher Denton, MD, Pediatric Hematology & Oncology, Hollywood, CA, Children's Hospital Los Angeles

ChristopherClementDentonMD

Pediatric Hematology & Oncology Hollywood, CA

Pediatric Anemia and Red Blood Cell Hematology, Pediatric Coagulation Disorder Hematology, Pediatric Platelet Disorder Hematology

Physician

Dr. Denton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Denton's full profile

Already have an account?

Education & Training

  • Children's Hospital Los Angeles
    Children's Hospital Los AngelesFellowship, Pediatric Hematology/Oncology, 2016 - 2019
  • University of Washington
    University of WashingtonResidency, Pediatrics, 2012 - 2015
  • Oregon Health and Science University School of Medicine
    Oregon Health and Science University School of MedicineClass of 2012

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2016 - 2025
  • WA State Medical License
    WA State Medical License 2012 - 2016
  • ID State Medical License
    ID State Medical License 2013 - 2014
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Lectures

  • Kidney Iron Deposition By R2* Is Associated with Hemolysis and Urinary IronClinically Relevant Abstract 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Hemolysis and Tricuspid Regurgitation Jet Velocity Predict Mortality in Patients with Sickle Cell Disease 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Corbus Pharmaceuticals Presents Data Demonstrating ACR CRISS Score Reflects Patient-Reported Outcomes at 6th Systemic Sclerosis World E-congress
    Corbus Pharmaceuticals Presents Data Demonstrating ACR CRISS Score Reflects Patient-Reported Outcomes at 6th Systemic Sclerosis World E-congressJune 29th, 2020
  • Treatment with Mycophenolate Mofetil and Cyclophosphamide Improves Patient-Reported Outcomes in Scleroderma Lung Disease
    Treatment with Mycophenolate Mofetil and Cyclophosphamide Improves Patient-Reported Outcomes in Scleroderma Lung DiseaseJune 10th, 2020
  • Move Along: Insights into Gastrointestinal Involvement in Systemic Sclerosis
    Move Along: Insights into Gastrointestinal Involvement in Systemic SclerosisOctober 21st, 2019
  • Join now to see all

Hospital Affiliations